Last week, President Joe Biden said he is working to ask Congress to provide additional funding for a new COVID-19 vaccine “that is necessary” and “that works.” This comes after reporting of a wave of new COVID cases across the country.

Biden seemed to suggest that new COVID booster requirements or guidelines could be on the horizon: “And tentatively, not decided finally yet, tentatively it is recommended that, it would likely be recommended [that] everybody get it [sic]. No matter whether they got it before or not.”

As a Johns Hopkins School of Medicine professor in an op-ed for The Wall Street Journal pointed out, no data has been released on how this new shot will affect humans even though the Food and Drug Administration is expected to release it shortly. This should be seen for the entirely standard-less and unprecedented way of introducing new drugs into society that it is, but it is now the norm for COVID-era drug policies.

Learn the benefits of becoming a Valuetainment Member and subscribe today!

NPR health correspondent Rob Stein reported that the new COVID vaccine was actually designed for a previous strain, but “are still a pretty close match” and “will cut the risk of catching the virus and spreading to others for at least a couple of months.” Stein was referring to the variants BA.2.86 and EG.5, and the new vaccines are only for one version of the omicron strain called XBB.1.5.

The unelected health experts seem to think that there will never be an end to COVID boosters. As Centers for Disease Control and Prevention (CDC) director Mandy Cohen said, while “Immunity is stronger today than at any other point in the outbreak” these antibodies are not permanent and “protection does decrease over time.”

Add comment